Article
Antidepressant switching as a proxy phenotype for drug non-response: investigating clinical, demographic and genetic characteristics
2024-11-10
Abstract excerpt
<h4>Background</h4> Selective serotonin reuptake inhibitors (SSRIs) are a first-line pharmacological therapy in major depressive disorder (MDD), but treatment response rates are low. Clinical trials lack the power to study the genetic contribution to SSRI response. Real-world evidence from electronic health records provides larger sample sizes, but novel response definitions are needed to accurately define SSRI no...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 192bd4d6-59c5-5470-bb1d-376c13dc3611
- DOI
- 10.1101/2024.11.09.24316987
